Showing results (1-10 of 105) with videos related to
Sort By:
Pageof 11
Frontiers in Pharmacology|February 7, 2022
Immunotherapy and Gene Therapy: New Challenges in the Diagnosis and Management of Drug-Induced Liver InjuryBénédicte Delire, Eleonora De Martin, Lucy Meunier, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 9, 2024
Drug-induced liver injury related to gene therapy: A new challenge to be managedDominique Larrey, Benedicte Delire, Lucy Meunier, et al.JHEP Reports : Innovation in Hepatology|July 4, 2024
CDK4/6 inhibitor-induced liver injury: Clinical phenotypes and role of corticosteroid treatmentLucy Meunier, Eleonora De Martin, Bénédicte Delire, et al.Annals of Hepatology|February 23, 2018
Recent Advances in Hepatotoxicity of Non Steroidal Anti-Inflammatory DrugsLucy Meunier, Dominique LarreyFrontiers in Pharmacology|January 11, 2020
Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and ValidationLucy Meunier, Dominique LarreyAnnals of Hepatology|February 17, 2020
Chemotherapy-associated steatohepatitisLucy Meunier, Dominique LarreyInternational Journal of Molecular Sciences|January 8, 2023
Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype SusceptibilityLucy Meunier, Dominique LarreyLiver International : Official Journal of the International Association for the Study of the Liver|January 27, 2025
Immune-Mediated Liver Injury From Checkpoint Inhibitor: An Evolving Frontier With Emerging ChallengesLily Dara, Eleonora De MartinClinics and Research in Hepatology and Gastroenterology|September 3, 2023
Acute liver failure following immune checkpoint inhibitorsThomas Renault, Lucy Meunier, Clément MonetJHEP Reports : Innovation in Hepatology|August 14, 2025
Navigating liver toxicity in the age of novel oncological agentsMar Riveiro-Barciela, Eleonora De MartinPageof 11